• Home
  • News
  • Fortune 500
  • Tech
  • Finance
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
LeadershipMartin Shkreli

Several Witnesses in the Martin Shkreli Case Are Worried About Retaliation

By
Reuters
Reuters
Down Arrow Button Icon
By
Reuters
Reuters
Down Arrow Button Icon
February 19, 2016, 2:22 PM ET
UNITED STATES - FEBRUARY 04: Martin Shkreli, former CEO Turing Pharmaceuticals, invoked his Fifth Amendment right against self-incrimination during a House Oversight and Government Reform Committee in Rayburn Building on "methods and reasoning behind recent drug price increases," February 04, 2016. Turing had raised the price of Daraprim, used by AIDS and cancer patients, from $13.50 to $750 a pill. (Photo By Tom Williams/CQ Roll Call)
Photograph by Tom Williams CQ-Roll Call — Getty Images

U.S. prosecutors said several witnesses in the criminal securities fraud case against notorious former pharmaceutical executive Martin Shkreli are concerned about retaliation and have received threats from him in the past.

Prosecutors cited the concern about witness intimidation in a brief filed late on Thursday in federal court in Brooklyn, N.Y., as they sought to delay a related Securities and Exchange Commission lawsuit.

The brief opposed a bid by Shkreli, 32, to take depositions and to obtain evidence in the SEC’s civil case, saying doing so would result in the early disclosure of information not normally available to defendants until late stages in criminal cases.

Among the reasons for putting the SEC case on hold, prosecutors said, was the “well-founded concern of witness intimidation based on defendant Shkreli’s past behavior.”

Shkreli’s lawyer, Benjamin Brafman, called those arguments “preposterous.”

“While his keen ‘intellect’ can at times be intimidating to mere mortals, nothing else about [Shkreli] is intimidating at all,” Brafman said in an email on Friday.

Shkreli, who gained notoriety as the head of Turing Pharmaceuticals when it raised the price of a drug to treat a parasitic infection to $750 from $13.50, was indicted in December and sued at the same time by the SEC.

Both cases allege Shkreli engaged in a Ponzi-like scheme, defrauding investors in his hedge fund MSMB Capital Management and misappropriating $11 million in assets from Retrophin, where he was then chief executive, to repay them.

Shkreli has pleaded not guilty and denied wrongdoing.

In Thursday’s brief, prosecutors cited evidence that Shkreli, 32, “has taken steps to intimidate or threaten individuals in the past,” including by engaging in a “campaign of harassment” against a former Retrophin employee in 2013.

Several witnesses cited Shkreli’s harassment of that employee as the reason they believe he may retaliate against them, prosecutors said. Several also said Shkreli has previously threatened them in personal and business disputes, prosecutors wrote.

At least one witness told authorities that Shkreli, in early 2015 while knowing he was under criminal investigation, reached out to him or her “and suggested that the witness agree to a false version of certain events,” prosecutors wrote.

About the Author
By Reuters
See full bioRight Arrow Button Icon

Latest in Leadership

Google.org
CommentaryTech
Nonprofits are solving 21st century problems—they need 21st century tech
By Maggie Johnson and Shannon FarleyDecember 8, 2025
32 minutes ago
Future of WorkCommentary
AI is rewriting the rules of work. Our job is to shape what comes next
By Jacqui CanneyDecember 8, 2025
42 minutes ago
Ray Yuen, office managing director at the design and architecture firm Gensler, speaks at Fortune's 2026 Brainstorm Design conference in Macau.
NewslettersFortune CHRO
If you want your employees back in the office, try feeding them, says Gensler executive
By Kristin StollerDecember 8, 2025
2 hours ago
man shooting at target bullseye and missing
NewslettersNext to Lead
The science of failing up: Why some leaders rise despite repeated screwups
By Ruth UmohDecember 8, 2025
3 hours ago
Justin Hotard, CEO of Nokia
CommentaryGen Z
Nokia CEO: The workforce is becoming AI-native. Leadership has to evolve
By Justin HotardDecember 8, 2025
4 hours ago
Ted Sarandos attends Netflix's "The New Yorker At 100" New York Screening at The Paris Theatre on December 04, 2025 in New York City.
NewslettersCEO Daily
Netflix needs Warner Bros.’s IP and franchises to remain the default streaming service
By Diane BradyDecember 8, 2025
4 hours ago

Most Popular

placeholder alt text
Real Estate
The 'Great Housing Reset' is coming: Income growth will outpace home-price growth in 2026, Redfin forecasts
By Nino PaoliDecember 6, 2025
2 days ago
placeholder alt text
AI
Nvidia CEO says data centers take about 3 years to construct in the U.S., while in China 'they can build a hospital in a weekend'
By Nino PaoliDecember 6, 2025
2 days ago
placeholder alt text
Economy
The most likely solution to the U.S. debt crisis is severe austerity triggered by a fiscal calamity, former White House economic adviser says
By Jason MaDecember 6, 2025
2 days ago
placeholder alt text
Politics
Supreme Court to reconsider a 90-year-old unanimous ruling that limits presidential power on removing heads of independent agencies
By Mark Sherman and The Associated PressDecember 7, 2025
23 hours ago
placeholder alt text
Economy
JPMorgan CEO Jamie Dimon says Europe has a 'real problem’
By Katherine Chiglinsky and BloombergDecember 6, 2025
2 days ago
placeholder alt text
Uncategorized
Transforming customer support through intelligent AI operations
By Lauren ChomiukNovember 26, 2025
12 days ago
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.